Indication:
Focus:
Chronic Pain
TRANSDUR™ Sufentanil A proprietary transdermal delivery system utilizing sufentanil, a potent opioid, for the treatment of chronic pain.
Learn more View complete product pipeline
July 29, 2010DURECT Corporation Invites You to Join Its Second Quarter 2010 Earnings Conference Call
July 28, 2010DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference
July 01, 2010DURECT Corporation Secures $50 Million Committed Equity Financing Facility
Learn more
